3 months ago
GMED
AnalystsVik ChopraVik Chopra's Stock Forecasts
AnalystsVik Chopra
Analyst Ranking
Top 28%
#1484 out of 5290 analysts
Average Return
+5.27%
Win Rate
47%14 out of 30
Risk vs Reward
Poor
Good
Vik Chopra's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuropace IncNPCE | +75.11% | $9.32 | $16.32 | 2025-08-12 - 2026-06-04 | Strong Buy |
Alphatec Holdings IncATEC | +59.34% | $6.64 | $10.58 | 2024-07-31 - 2025-07-31 | Strong Buy |
Neuropace IncNPCE | +47.54% | $9.15 | $13.50 | 2024-11-12 - 2025-11-12 | Strong Buy |
Neuropace IncNPCE | +37.67% | $6.77 | $9.32 | 2024-08-13 - 2025-08-13 | Strong Buy |
Globus Medical IncGMED | +36.40% | $58.65 | $80.00 | 2025-08-07 - 2026-06-04 | Strong Buy |
Vik Chopra Analyst Color
Get additional color on Vik Chopra's coverage of popular stocks
a year ago
MASI
Vik Chopra's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Solventum CorpSOLV | 6 | Hold | $83.00 | +0.70% | Maintains | 3 months ago |
Integra Lifesciences Holdings CorpIART | 3 | Hold | $12.00 | -31.66% | Maintains | 3 months ago |
Dentsply Sirona IncXRAY | 5 | Hold | $13.00 | +31.58% | Maintains | 3 months ago |
Globus Medical IncGMED | 12 | Strong Buy | $104.00 | +30.00% | Maintains | 3 months ago |
Henry Schein IncHSIC | 4 | Hold | $87.00 | +14.02% | Maintains | 3 months ago |
Masimo CorpMASI | 11 | Hold | $180.00 | +0.61% | Downgrades | 4 months ago |
Envista Holdings CorpNVST | 4 | Hold | $26.00 | +13.69% | Maintains | 4 months ago |
Align Technology IncALGN | 5 | Strong Buy | $200.00 | +18.84% | Maintains | 4 months ago |
Conmed CorpCNMD | 7 | Hold | $42.00 | +19.56% | Maintains | 4 months ago |
Enovis CorpENOV | 5 | Strong Buy | $42.00 | +83.73% | Maintains | 7 months ago |
Neuropace IncNPCE | 4 | Strong Buy | $16.00 | -1.96% | Maintains | 7 months ago |
Alphatec Holdings IncATEC | 2 | Strong Buy | $16.00 | +102.02% | Maintains | 8 months ago |
Nuvasive IncNUVA | 2 | Hold | $57.72 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.